Member Companies

Membership in IQ is open to any corporation and/or any subsidiary thereof which is significantly engaged in the development of new chemical entities or new molecular entities for the prevention, diagnosis or treatment of disease. For information about joining the Consortium, please see Join IQ.

Current IQ Consortium members include:

AbbVie

Agios

Allergan

Alnylam

Amgen, Inc

Astellas Pharma US LLC

AstraZeneca Pharmaceuticals

Baxter Healthcare Corporation

Bayer HealthCare

Biogen

Blueprint Medicines

Boehringer Ingelheim

Bristol-Myers Squibb Company

Celgene Corporation

Daiichi Sankyo

Eisai, Inc.

Eli Lilly and Company

EMD Serono

Genentech

Gilead Sciences

GlaxoSmithKline

Incyte Corporation

Ironwood Pharmaceuticals

Johnson & Johnson

Merck & Co.

Mitsubishi Tanabe

Novartis

 

Otsuka Pharmaceutical Co.

Pfizer

Roche

Sanofi

Sarepta

Seattle Genetics

Shire

Sunovion

Takeda

Teva Pharmaceutical

Theravance Biopharma

UCB Pharma

Vertex, Inc.